Objective: To develop clinical practice guidelines for the management of patients with
primary aldosteronism. Participants: The Task Force included a chair, selected by the …

Objective: Our objective was to develop clinical practice guidelines for the diagnosis and
treatment of patients with primary aldosteronism. Participants: The Task Force comprised a …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Primary aldosteronism is much more common than previously thought. The high prevalence
of primary aldosteronism, the damage this condition does to the heart, blood vessels and …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Primary aldosteronism (PA) is the most common secondary form of arterial hypertension,
with a particularly high prevalence among patients with resistant hypertension. Aldosterone …

The Japan Endocrine Society (JES) attempted to develop guidelines for the diagnosis and
treatment of primary aldosteronism (PA). The Task Force Committee (TFC) was composed of …

Primary aldosteronism is caused by bilateral idiopathic hyperplasia in approximately two-
thirds of cases and aldosterone-producing adenoma in one-third. Most patients with primary …

Abstract Primary aldosteronism affects 5–13% of patients with hypertension. Patients with
hypertension and hypokalemia and most patients with treatment-resistant hypertension …

Primary aldosteronism used to be considered a rare cause of secondary hypertension.
However, accruing evidence indicates that primary aldosteronism is more common than …